Clinical Trials Browser

Phase 2 × Advanced Breast Cancer × cediranib × Clear all

NCT00454805 2016-08-03

AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.

Phase 2 Completed

75 enrolled 11 charts

Advanced Breast Cancer